Table 1 Baseline characteristics of patients and biochemical analyses before and after MIP
From: Atypical parathyroid adenoma: clinical and anatomical pathologic features
| Â | Total population |
|---|---|
n = 117 | |
Male, n (%) | 35 (29.9) |
Age (year) | 60 ± 13 |
BMI (kg/m2) | 25.5 ± 4.0 |
Symptomatic hypercalcemia | 19 (16.2) |
Nephrolithiasis | 36 (30.8) |
Peptic ulcers | 3 (2.6) |
Pancreatitis | 4 (3.4) |
Cardiovascular disease | 18 (15.4) |
Hypertension | 55 (47.0) |
Osteoporosis | 27 (23.1) |
Fragility fracture | 3 (2.6) |
Neuropsychiatric/neurocognitive symptoms | 7 (6.0) |
Neuromuscular symptoms | 6 (5.1) |
CrCl < 60 ml/min | 11 (9.4) |
Others symptoms | 16 (13.7) |
Serum creatinine (mg/dL) | 1.2 ± 0.7 |
eGFR (mL/min) | 89.2 ± 38.1 |
Preoperative serum calcium (mg/dL) | 11.8 ± 2.1 |
25-OH vitamin D (ng/mL) | 53.5 ± 15.6 |
24-h urinary calcium | 279.1 ± 112.1 |
Preoperatve iPTH (pg/ml) | 459.2 ± 602.1 |
Intraoperative iPTH (pg/ml) | 59.7 ± 71.1 |
Postoperative iPTH (pg/ml) | 25.3 ± 17.3 |
6 months iPTH (pg/ml) | 23.0 ± 9.8 |
I postoperative day serum calcium (mg/dL) | 9.1 ± 0.6 |
II postoperative day serum calcium (mg/dL) | 9.0 ± 0.6 |
III postoperative day serum calcium (mg/dL) | 8.9 ± 0.5 |
Follow-up time (months) | 60 ± 1 |
Temporary hypoparathyroidism | 7 (6.0) |
Permanent hypoparathyroidism | 0 (0.0) |
Persistent hyperparathyroidism | 0 (0.0) |
Recurrence hyperparathyroidism | 0 (0.0) |
Disease relapse | 0 (0.0) |